To overcome the limitation of small region detection using PET, anti-CD8 immuno-PET based on 89Zr-malDFO-169 cDb not only detected lymph nodes in mice via targeting tumor-infiltrating CD8+ T cells, but also provided a preclinical evaluation for antitumor immune responses of immunotherapy through tracking dynamic distribution of T-cells. Here, CD8A is linked to neoplasm.